+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Viscosupplementation Market Research Report by Product (Five Injection, Single Injection, and Three Injection), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4986027
  • Report
  • July 2021
  • Region: Global, North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • 184 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Viscosupplementation Market will Grow to USD 3,393.24 Million by 2026, at a CAGR of 5.98%

FEATURED COMPANIES

  • Alcon Vision LLC
  • Anika Therapeutics, Inc.
  • Contipro A.S.
  • Ferring B.V.
  • LG Life Sciences Ltd
  • Mylan N.V.
  • MORE
The Global Viscosupplementation Market size was estimated at USD 2,394.51 Million in 2020 and expected to reach USD 2,529.65 Million in 2021, at a Compound Annual Growth Rate (CAGR) 5.98% to reach USD 3,393.24 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Viscosupplementation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Viscosupplementation Market was examined across Five Injection, Single Injection, and Three Injection.
  • Based on Geography, the Viscosupplementation Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Viscosupplementation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Viscosupplementation Market, including Alcon Vision LLC, Allergan, Inc., Anika Therapeutics, Inc., Bausch Health Companies Inc, Bioventus LLC, Chugai Pharmaceutical Co., Ltd., Contipro A.S., F. Hoffmann-La Roche AG, Ferring B.V., Fidia Farmaceutici S.P.A., Galderma Laboratories, L.P., Johnson & Johnson Services, Inc, LG Life Sciences Ltd, Lifecore Biomedical, LLC, Mylan N.V., OrthogenRx, Inc, Regen Lab SA, Salix Pharmaceuticals, Inc., Sanofi S.A., Seikagaku Corporation, Smith & Nephew Plc, Teva Pharmaceutical Industries Ltd, and Zimmer Biomet.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Viscosupplementation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viscosupplementation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viscosupplementation Market?
4. What is the competitive strategic window for opportunities in the Global Viscosupplementation Market?
5. What are the technology trends and regulatory frameworks in the Global Viscosupplementation Market?
6. What is the market share of the leading vendors in the Global Viscosupplementation Market?
7. What modes and strategic moves are considered suitable for entering the Global Viscosupplementation Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alcon Vision LLC
  • Anika Therapeutics, Inc.
  • Contipro A.S.
  • Ferring B.V.
  • LG Life Sciences Ltd
  • Mylan N.V.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Geography Outlook
3.5. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing need for non-surgical treatment for osteoarthritis
5.1.1.2. Rising occurrence of lifestyle-induced disorders with changing eating habits
5.1.1.3. Surge in geriatric population and obesity globally
5.1.2. Restraints
5.1.2.1. Dearth of efficiency and product safety
5.1.2.2. High cost of the hyaluronic acid-based treatment
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in the development of hyaluronic acid-based therapies
5.1.3.2. Increasing research and development for product expansion
5.1.4. Challenges
5.1.4.1. Strict regulatory mandates for approval coupled with short duration of lubrication and pain relief
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Viscosupplementation Market, by Product
6.1. Introduction
6.2. Five Injection
6.3. Single Injection
6.4. Three Injection

7. Americas Viscosupplementation Market
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States

8. Asia-Pacific Viscosupplementation Market
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. Singapore
8.10. South Korea
8.11. Thailand

9. Europe, Middle East & Africa Viscosupplementation Market
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom

10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis, By Key Player
10.4. Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion

11. Company Usability Profiles
11.1. Alcon Vision LLC
11.2. Allergan, Inc.
11.3. Anika Therapeutics, Inc.
11.4. Bausch Health Companies Inc
11.5. Bioventus LLC
11.6. Chugai Pharmaceutical Co., Ltd.
11.7. Contipro A.S.
11.8. F. Hoffmann-La Roche AG
11.9. Ferring B.V.
11.10. Fidia Farmaceutici S.P.A.
11.11. Galderma Laboratories, L.P.
11.12. Johnson & Johnson Services, Inc
11.13. LG Life Sciences Ltd
11.14. Lifecore Biomedical, LLC
11.15. Mylan N.V.
11.16. OrthogenRx, Inc
11.17. Regen Lab SA
11.18. Salix Pharmaceuticals, Inc.
11.19. Sanofi S.A.
11.20. Seikagaku Corporation
11.21. Smith & Nephew Plc
11.22. Teva Pharmaceutical Industries Ltd
11.23. Zimmer Biomet

12. Appendix
12.1. Discussion Guide
12.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET: MARKET DYNAMICS
FIGURE 6. GLOBAL VISCOSUPPLEMENTATION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2026
FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, 2018-2026 (USD MILLION)
FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 17. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 19. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 20. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 21. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 22. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 24. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 25. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 27. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 28. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 29. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 30. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 31. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 32. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 33. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 34. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 35. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 36. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 37. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 40. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 41. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 42. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 43. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 44. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 45. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 46. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 47. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 48. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 49. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 50. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL VISCOSUPPLEMENTATION MARKET: FPNV POSITIONING MATRIX
FIGURE 52. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VISCOSUPPLEMENTATION MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL VISCOSUPPLEMENTATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 10. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 11. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 12. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 13. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 16. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 17. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 18. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 19. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 20. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 21. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 22. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 23. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 24. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 25. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 26. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 27. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 30. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 31. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 32. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 33. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 34. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 35. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 36. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 37. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 38. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 39. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 40. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 41. GLOBAL VISCOSUPPLEMENTATION MARKET: SCORES
TABLE 42. GLOBAL VISCOSUPPLEMENTATION MARKET: BUSINESS STRATEGY
TABLE 43. GLOBAL VISCOSUPPLEMENTATION MARKET: PRODUCT SATISFACTION
TABLE 44. GLOBAL VISCOSUPPLEMENTATION MARKET: RANKING
TABLE 45. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 46. GLOBAL VISCOSUPPLEMENTATION MARKET: MERGER & ACQUISITION
TABLE 47. GLOBAL VISCOSUPPLEMENTATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 48. GLOBAL VISCOSUPPLEMENTATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 49. GLOBAL VISCOSUPPLEMENTATION MARKET: INVESTMENT & FUNDING
TABLE 50. GLOBAL VISCOSUPPLEMENTATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 51. GLOBAL VISCOSUPPLEMENTATION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Alcon Vision LLC
  • Allergan, Inc.
  • Anika Therapeutics, Inc.
  • Bausch Health Companies Inc
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Contipro A.S.
  • F. Hoffmann-La Roche AG
  • Ferring B.V.
  • Fidia Farmaceutici S.P.A.
  • Galderma Laboratories, L.P.
  • Johnson & Johnson Services, Inc
  • LG Life Sciences Ltd
  • Lifecore Biomedical, LLC
  • Mylan N.V.
  • OrthogenRx, Inc
  • Regen Lab SA
  • Salix Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Seikagaku Corporation
  • Smith & Nephew Plc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll